<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/EAAD4D43-BD15-432B-9385-2DBD0C65958D"><gtr:id>EAAD4D43-BD15-432B-9385-2DBD0C65958D</gtr:id><gtr:name>University of Bath</gtr:name><gtr:department>Chemistry</gtr:department><gtr:address><gtr:line1>University of Bath</gtr:line1><gtr:line2>Claverton Down</gtr:line2><gtr:line4>Bath</gtr:line4><gtr:line5>Avon</gtr:line5><gtr:postCode>BA2 7AY</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/EAAD4D43-BD15-432B-9385-2DBD0C65958D"><gtr:id>EAAD4D43-BD15-432B-9385-2DBD0C65958D</gtr:id><gtr:name>University of Bath</gtr:name><gtr:address><gtr:line1>University of Bath</gtr:line1><gtr:line2>Claverton Down</gtr:line2><gtr:line4>Bath</gtr:line4><gtr:line5>Avon</gtr:line5><gtr:postCode>BA2 7AY</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/D70FF4F0-9C68-42A5-B9D9-FDAB71D0631B"><gtr:id>D70FF4F0-9C68-42A5-B9D9-FDAB71D0631B</gtr:id><gtr:name>Biocontrol Ltd</gtr:name><gtr:address><gtr:line1>Cranfield Innovation Centre</gtr:line1><gtr:line2>University Way</gtr:line2><gtr:line3>Cranfield Technology Park</gtr:line3><gtr:line4>Bedford</gtr:line4><gtr:line5>Bedfordshire</gtr:line5><gtr:postCode>MK43 0BT</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/F0DE12EC-900B-4C67-BB76-67A5C13B8ADC"><gtr:id>F0DE12EC-900B-4C67-BB76-67A5C13B8ADC</gtr:id><gtr:name>Frenchay Hospital</gtr:name><gtr:address><gtr:line1>Frenchay Hospital</gtr:line1><gtr:line2>Frenchay Park Road</gtr:line2><gtr:line3>Frenchay</gtr:line3><gtr:line4>Bristol</gtr:line4><gtr:postCode>BS16 1LE</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/A6D1214E-CB09-402D-9678-9BF526600A88"><gtr:id>A6D1214E-CB09-402D-9678-9BF526600A88</gtr:id><gtr:firstName>Andrew Tobias Aveling</gtr:firstName><gtr:surname>Jenkins</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/8A2A0D9B-16DC-46D2-B5B4-1B5690405449"><gtr:id>8A2A0D9B-16DC-46D2-B5B4-1B5690405449</gtr:id><gtr:firstName>Thomas</gtr:firstName><gtr:otherNames>Cranstoun</gtr:otherNames><gtr:surname>Arnot</gtr:surname><gtr:orcidId>0000-0002-7950-9429</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=EP%2FI027602%2F1"><gtr:id>1BCC657E-AFF2-402E-BC6F-D9007C52ECAD</gtr:id><gtr:title>Encapsulated phage for treatment of burns and wound site infections</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>EP/I027602/1</gtr:grantReference><gtr:abstractText>This project, in partnership with Biocontrol Ltd and the departments of Chemistry and Chemical Engineering at the University of Bath, will encapsulate specific lytic phages within phospholipid vesicles, and incorporate the vesicles into a prototype burn / wound dressing and a topical aqueous cream. The primary focus of the work is in the prevention of infection of paediatric burns, where our clinical partner, Dr Amber Young at the South West Paediatric Burns Centre, Frenchay hospital will provide expertise. The vesicles will be designed such that they both will stabilize the phage over time i.e. when stored, but only release their contents following exposure to secreted toxins and enzymes from pathogenic bacteria. The aim of this project is to reduce the risk of infection from burns and other injuries by making a 'smart' dressing, based on phage therapeutics.38,000 children on average suffer burn injuries in England and Wales each year, of which 55% are scalds. Most are small in area, 80% are in children under five years and the majority are due to hot drink spillages. One of the primary problems in the treatment of burns is bacterial infection, which can delay healing, increase pain; increase the risk of scarring and in some cases cause death. In recent years there have been great improvements in the treatment of burns, particularly with biologically-derived dressings which actively promote cell growth. However, the problem of infection has not gone away, and there is evidence that silver treated antimicrobial dressings can delay burn healing.</gtr:abstractText><gtr:potentialImpactText>The development of novel antibacterial technology to reduce morbidity, mortality and healthcare costs due to bacterial wound / surgical site infections and infections of burns is the overarching goal of this project. The four organisms targeted in this proposal are responsible for the majority of infections of burns and wound / surgical site infections and these agents are frequently multiply antibiotic resistant and in some cases may be unresponsive to current antibiotic classes. The problem of infection is especially acute in burns: 38,000 children suffer from burn injuries in the UK each year (Hospital Episode Statistics data 2002). The children's Burn Centre in Bristol admits several hundred such children annually. The clinical concern for these children is mainly one of burn wound infection. One particular infection is Toxic Shock Syndrome an endotoxaemia secondary to S. aureus which has an incidence of 2.5% and, of those that get the full-blown disease, a mortality of up to 50%. Current dressings encourage healing but have no effective anti-bacterial properties. The utilization of naturally occurring phages for delivery to infection sites to replace antibiotic therapy will decrease the selective pressure for the evolution of antibiotic resistant bacteria. This would be particularly pronounced in treating multiply- and pan- antibiotic resistant infections and frequent use of phage therapies would be expected to decrease the burden of antibiotic resistant infections a stated policy aim of health services worldwide. People Scientists working in the fields of chemistry and chemical engineering at University of Bath will be collaborating with life scientists at Biocontrol Ltd to in basic and applied fields and huge potential exists for the cross-pollination of research expertise between these institutions and between the clinical partner and industry partners such as Mlnlycke or Hartman AG. The training of two research students and a postdoctoral researcher in this richly collaborative environment with frequent visits to the relevant institutes will provide a rare mix of different training experiences and skill sets for the funded researchers with exposure to basic and applied research projects for each individual. The association of Biocontrol Ltd with this project will provide opportunities for employment of researchers beyond the funding term of this project in a company that is expanding rapidly having relocated to new laboratories and offices in Colworth Science park in May 2010. Economy Biocontrol Ltd is currently almost entirely investor funded although small grants have been secured from smaller charities and regional development funds in the past including the European Cystic Fibrosis Society. The company's phase I/IIa clinical trials in animals and humans have been self-funded but larger scale, phase III trials will require substantial external investment which will be attracted by dissemination of the achievement of the basic and applied research goals of the work packages in this proposal. , The award of this grant in itself will help attract funding for the company's laboratory and clinical studies with the prospects for the future employment of research and development scientists and other personnel in the future. With the exception of P. aeruginosa the company's work on the three other organisms named in this proposal has thus far been under-exploited - the potential for phage products to treat S. aureus, A. baumannii and K. pneumonia would be expected to target part of a global annual multi-billion dollar market for anti-infectives.</gtr:potentialImpactText><gtr:fund><gtr:end>2015-05-01</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/798CB33D-C79E-4578-83F2-72606407192C"><gtr:id>798CB33D-C79E-4578-83F2-72606407192C</gtr:id><gtr:name>EPSRC</gtr:name></gtr:funder><gtr:start>2011-05-02</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>657967</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>'Pint of Science' talk, Bath</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>381EA735-0988-46D0-95D6-A74C21F56025</gtr:id><gtr:impact>Discussed use of bacteriophage in future therapy to a general public audience

Good Q and A session</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://pintofscience.co.uk/events/bath/</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Plenary talk at conference: CASE 2014</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>9B5360B5-C7BA-45FE-8058-7C20B32BC474</gtr:id><gtr:impact>Stimulated interest in research

Future collaborations with Nanjing University</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:url>http://case2014.wordpress.com/</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>10000000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Smart Nanotherapeutic Wound Dressings to Treat Bacterial Infection: Exploiting Bacterial Toxin-Triggered Release of Novel Natural Antimicrobial Agents from Nanocapsules</gtr:description><gtr:end>2019-12-02</gtr:end><gtr:fundingOrg>European Commission (EC)</gtr:fundingOrg><gtr:fundingRef>Smartwound</gtr:fundingRef><gtr:id>2D101F46-1385-4DDE-B7BD-67D1C38D9813</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>905000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC DPFS</gtr:description><gtr:end>2018-09-02</gtr:end><gtr:fundingOrg>MRC-UK</gtr:fundingOrg><gtr:fundingRef>MR/N006496/1</gtr:fundingRef><gtr:id>7B7429F1-BFCB-41EE-B249-61B5C95C8A5C</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2015-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>Patent protects the vesicle release technology developed during this grant and now underpinning our current wound dressing development programme</gtr:description><gtr:id>F370EDAD-B7B3-4788-95C2-2D6444C5B2AB</gtr:id><gtr:impact>In discssion with industry partners for upscaling and comemrcial development of technology</gtr:impact><gtr:licensed>Commercial In Confidence</gtr:licensed><gtr:patentId>US9499852B2</gtr:patentId><gtr:protection>Patent granted</gtr:protection><gtr:title>Wound dressing</gtr:title><gtr:yearProtectionGranted>2016</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:keyFindingsOutput><gtr:description>- Bacteriophage can be used to control bacterial infection
- Cocktails of phage are more effective than single phage
- Phage secrete enzymes which help to breakdown biofilms
- Two layer films were created containing phage, which released phage following a stimulus from infective S. aureus</gtr:description><gtr:exploitationPathways>Work patented and used in current development grant (funded by MRC).

Results that are published being used by other research groups and companies</gtr:exploitationPathways><gtr:id>278C799B-54E0-4CEB-A802-E6CA8E7E0745</gtr:id><gtr:sectors><gtr:sector>Healthcare</gtr:sector></gtr:sectors></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs><gtr:productOutput><gtr:clinicalTrial>true</gtr:clinicalTrial><gtr:description>Laboratory observational Ex-Vivo study to investigate the sensitivity and specificity of a smart dressing to detect clinically relevant wound infection

Burn wound infections are difficult to diagnose, but may become serious if they are not treated quickly. To diagnose an infection, dressings need to be removed from the wound, which may slow the healing process. A new dressing Smartwound? may help to diagnose wound infection without needing to remove the dressing. The Smartwound? dressing changes colour in the presence of the infection-causing bacteria. Laboratory studies show that the dressing does change colour in the presence of bacteria, but before it can be used in patients, it needs to be tested with the bacteria found in human wounds. The new Smartwound? dressing will not be tested on patients in this study. Samples of burn wound fluid, called exudate, which can be taken from wound swabs and used wound dressings when the patients have their dressings removed will be used. Exudate will be gathered from patients with and without wound infection to see whether the dressing changes colour in the presence of the bacteria that cause a wound infection. Dressing changes and swabs are part of the normal care routine for patients with burns. This study aims to test whether the Smartwound? technology developed to detect infection in a dressing for burn wounds is effective in identifying infection.</gtr:description><gtr:id>D59705A1-0806-4794-B182-85825A2388C9</gtr:id><gtr:impact>This trial will give key supportive data about the sensitivity and specificity of our diagnostic wound dressing, which will leverage next level of funding from industrial collaborators. Also as well as helping to inform a clinical definition of burn wound infection.</gtr:impact><gtr:stage>Refinement.  Clinical</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>Diagnostic wound dressing</gtr:title><gtr:type>Diagnostic Tool - Non-Imaging</gtr:type><gtr:yearDevCompleted>2016</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C71468CA-78BB-4DDC-875E-1EEEEC4D502D"><gtr:id>C71468CA-78BB-4DDC-875E-1EEEEC4D502D</gtr:id><gtr:title>Visible, colorimetric dissemination between pathogenic strains of Staphylococcus aureus and Pseudomonas aeruginosa using fluorescent dye containing lipid vesicles.</gtr:title><gtr:parentPublicationTitle>Biosensors &amp; bioelectronics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/dab6be183ed73741479d9a1fda2f04ad"><gtr:id>dab6be183ed73741479d9a1fda2f04ad</gtr:id><gtr:otherNames>Thet NT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0956-5663</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/994F0B99-7955-4E29-A37F-929C7A0E3CB6"><gtr:id>994F0B99-7955-4E29-A37F-929C7A0E3CB6</gtr:id><gtr:title>A new assay for rhamnolipid detection-important virulence factors of Pseudomonas aeruginosa.</gtr:title><gtr:parentPublicationTitle>Applied microbiology and biotechnology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/37cbe2871213caf27014ec21f7611ef3"><gtr:id>37cbe2871213caf27014ec21f7611ef3</gtr:id><gtr:otherNames>Laabei M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0175-7598</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2022E553-C382-4DF8-8D9D-C77DA101D85F"><gtr:id>2022E553-C382-4DF8-8D9D-C77DA101D85F</gtr:id><gtr:title>Combined use of bacteriophage K and a novel bacteriophage to reduce Staphylococcus aureus biofilm formation.</gtr:title><gtr:parentPublicationTitle>Applied and environmental microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d5ee429f576b3c7690b29c3a0389ce5b"><gtr:id>d5ee429f576b3c7690b29c3a0389ce5b</gtr:id><gtr:otherNames>Alves DR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0099-2240</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/8E70ABA9-4820-42F6-8C5E-A0D012984489"><gtr:id>8E70ABA9-4820-42F6-8C5E-A0D012984489</gtr:id><gtr:title>Effect of lipid and fatty acid composition of phospholipid vesicles on long-term stability and their response to Staphylococcus aureus and Pseudomonas aeruginosa supernatants.</gtr:title><gtr:parentPublicationTitle>Langmuir : the ACS journal of surfaces and colloids</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c078f8fff8faaee0b091f5725046ff4d"><gtr:id>c078f8fff8faaee0b091f5725046ff4d</gtr:id><gtr:otherNames>Marshall SE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0743-7463</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0E320254-E945-4554-9977-DF73D13787F3"><gtr:id>0E320254-E945-4554-9977-DF73D13787F3</gtr:id><gtr:title>Enhancement of the antimicrobial properties of bacteriophage-K via stabilization using oil-in-water nano-emulsions.</gtr:title><gtr:parentPublicationTitle>Biotechnology progress</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/be0129a7f6c21be52149937591b43673"><gtr:id>be0129a7f6c21be52149937591b43673</gtr:id><gtr:otherNames>Esteban PP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1520-6033</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C92D37E2-C2FE-4361-8F57-B10BD747FF93"><gtr:id>C92D37E2-C2FE-4361-8F57-B10BD747FF93</gtr:id><gtr:title>Triggered Release of Bacteriophage K from Agarose/Hyaluronan Hydrogel Matrixes byStaphylococcus aureusVirulence Factors</gtr:title><gtr:parentPublicationTitle>Chemistry of Materials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/71efdc202ebb4588fdf63c7a0e3747b4"><gtr:id>71efdc202ebb4588fdf63c7a0e3747b4</gtr:id><gtr:otherNames>Bean J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B54DBEE2-AB99-437B-97EC-307B295E23DE"><gtr:id>B54DBEE2-AB99-437B-97EC-307B295E23DE</gtr:id><gtr:title>Advanced dextran based nanogels for fighting Staphylococcus aureus infections by sustained zinc release</gtr:title><gtr:parentPublicationTitle>J. Mater. Chem. B</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/282650245147d86fa095c33c4689b2cf"><gtr:id>282650245147d86fa095c33c4689b2cf</gtr:id><gtr:otherNames>Malzahn K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/41591DE4-813C-4139-BE10-A7CC2DBE4F92"><gtr:id>41591DE4-813C-4139-BE10-A7CC2DBE4F92</gtr:id><gtr:title>Poly(N-isopropylacrylamide-co-allylamine) (PNIPAM-co-ALA) nanospheres for the thermally triggered release of Bacteriophage K.</gtr:title><gtr:parentPublicationTitle>European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8959c8054fdf813e895fc6b2ed4cb785"><gtr:id>8959c8054fdf813e895fc6b2ed4cb785</gtr:id><gtr:otherNames>Hathaway H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0939-6411</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/25608B5D-EBFA-4020-B222-E891795E4E88"><gtr:id>25608B5D-EBFA-4020-B222-E891795E4E88</gtr:id><gtr:title>An electrochemical sensor concept for the detection of bacterial virulence factors from Staphylococcus aureus and Pseudomonas aeruginosa</gtr:title><gtr:parentPublicationTitle>Electrochemistry Communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/2c595b7c97c400cf18aab74cf4ef2b8c"><gtr:id>2c595b7c97c400cf18aab74cf4ef2b8c</gtr:id><gtr:otherNames>Thet N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C2170985-E3C5-453D-9EBB-7AF29C669AAE"><gtr:id>C2170985-E3C5-453D-9EBB-7AF29C669AAE</gtr:id><gtr:title>A novel bacteriophage cocktail reduces and disperses Pseudomonas aeruginosa biofilms under static and flow conditions.</gtr:title><gtr:parentPublicationTitle>Microbial biotechnology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d5ee429f576b3c7690b29c3a0389ce5b"><gtr:id>d5ee429f576b3c7690b29c3a0389ce5b</gtr:id><gtr:otherNames>Alves DR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1751-7915</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/4F063F59-9D82-4A12-A7D8-B65AD8111A20"><gtr:id>4F063F59-9D82-4A12-A7D8-B65AD8111A20</gtr:id><gtr:title>Prototype Development of the Intelligent Hydrogel Wound Dressing and Its Efficacy in the Detection of Model Pathogenic Wound Biofilms.</gtr:title><gtr:parentPublicationTitle>ACS applied materials &amp; interfaces</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/dab6be183ed73741479d9a1fda2f04ad"><gtr:id>dab6be183ed73741479d9a1fda2f04ad</gtr:id><gtr:otherNames>Thet NT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1944-8244</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/8A08152E-0CE1-4242-9F30-363D1B1D5C3F"><gtr:id>8A08152E-0CE1-4242-9F30-363D1B1D5C3F</gtr:id><gtr:title>Intelligent Surfaces in Biotechnology</gtr:title><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/174c4a940a14c1760c1d7dffefe048eb"><gtr:id>174c4a940a14c1760c1d7dffefe048eb</gtr:id><gtr:otherNames>Griesser H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/991D88C7-91C6-48E5-AA38-1BDB0E488603"><gtr:id>991D88C7-91C6-48E5-AA38-1BDB0E488603</gtr:id><gtr:title>Poly(N-isopropylacrylamide-co-allylamine) (PNIPAM-co-ALA) nanospheres for the thermally triggered release of Bacteriophage K.</gtr:title><gtr:parentPublicationTitle>European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8959c8054fdf813e895fc6b2ed4cb785"><gtr:id>8959c8054fdf813e895fc6b2ed4cb785</gtr:id><gtr:otherNames>Hathaway H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0939-6411</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/BD778F28-735B-46BB-A231-61CD2DDF96A7"><gtr:id>BD778F28-735B-46BB-A231-61CD2DDF96A7</gtr:id><gtr:title>Studying the cytolytic activity of gas plasma with self-signalling phospholipid vesicles dispersed within a gelatin matrix</gtr:title><gtr:parentPublicationTitle>Journal of Physics D: Applied Physics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/2d442b7b00f8069dbadaddb5e6bd547f"><gtr:id>2d442b7b00f8069dbadaddb5e6bd547f</gtr:id><gtr:otherNames>Marshall S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D10D8694-D44C-4EFA-A150-FFFE331A5E91"><gtr:id>D10D8694-D44C-4EFA-A150-FFFE331A5E91</gtr:id><gtr:title>Assessing phage therapy against Pseudomonas aeruginosa using a Galleria mellonella infection model.</gtr:title><gtr:parentPublicationTitle>International journal of antimicrobial agents</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/09364ab78dbad508f9d5b23a281ccbcb"><gtr:id>09364ab78dbad508f9d5b23a281ccbcb</gtr:id><gtr:otherNames>Beeton ML</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0924-8579</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2DFD0854-9332-4D8F-8E6F-A475F96D7853"><gtr:id>2DFD0854-9332-4D8F-8E6F-A475F96D7853</gtr:id><gtr:title>In vitro studies of toxic shock toxin-1-secreting Staphylococcus aureus and implications for burn care in children.</gtr:title><gtr:parentPublicationTitle>The Pediatric infectious disease journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/37cbe2871213caf27014ec21f7611ef3"><gtr:id>37cbe2871213caf27014ec21f7611ef3</gtr:id><gtr:otherNames>Laabei M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0891-3668</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/41D4C3A5-A831-41F9-90D9-CD6518780D74"><gtr:id>41D4C3A5-A831-41F9-90D9-CD6518780D74</gtr:id><gtr:title>Photopolymerization of polydiacetylene in hybrid liposomes: effect of polymerization on stability and response to pathogenic bacterial toxins.</gtr:title><gtr:parentPublicationTitle>The journal of physical chemistry. B</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/dab6be183ed73741479d9a1fda2f04ad"><gtr:id>dab6be183ed73741479d9a1fda2f04ad</gtr:id><gtr:otherNames>Thet NT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1520-5207</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/54969A01-A5F3-4432-8A56-FD5D22FE8E0D"><gtr:id>54969A01-A5F3-4432-8A56-FD5D22FE8E0D</gtr:id><gtr:title>Ionized gas (plasma) delivery of reactive oxygen species (ROS) into artificial cells</gtr:title><gtr:parentPublicationTitle>Journal of Physics D: Applied Physics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/713a3755b3928a4c4ec455f3c22d25cb"><gtr:id>713a3755b3928a4c4ec455f3c22d25cb</gtr:id><gtr:otherNames>Hong S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/93C5ECAE-BA73-48CC-93D6-EB48FB476C4B"><gtr:id>93C5ECAE-BA73-48CC-93D6-EB48FB476C4B</gtr:id><gtr:title>Triggered Release of Bacteriophage K from Agarose/Hyaluronan Hydrogel Matrixes byStaphylococcus aureusVirulence Factors</gtr:title><gtr:parentPublicationTitle>Chemistry of Materials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/71efdc202ebb4588fdf63c7a0e3747b4"><gtr:id>71efdc202ebb4588fdf63c7a0e3747b4</gtr:id><gtr:otherNames>Bean J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/55F49AD1-F683-4841-A852-053FD19E74DB"><gtr:id>55F49AD1-F683-4841-A852-053FD19E74DB</gtr:id><gtr:title>Staphylococcus aureus interaction with phospholipid vesicles--a new method to accurately determine accessory gene regulator (agr) activity.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/37cbe2871213caf27014ec21f7611ef3"><gtr:id>37cbe2871213caf27014ec21f7611ef3</gtr:id><gtr:otherNames>Laabei M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">EP/I027602/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects><gtr:researchSubject><gtr:id>F442B6BE-8B89-4C01-8D3B-E8A4D320B672</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Biomolecules &amp; biochemistry</gtr:text></gtr:researchSubject><gtr:researchSubject><gtr:id>60EBB420-734E-4DB5-B0F2-65A1115A27F8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Chemical synthesis</gtr:text></gtr:researchSubject></gtr:researchSubjects><gtr:researchTopics><gtr:researchTopic><gtr:id>0B9701E7-D17F-4963-82DA-B3926A65B50A</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Biological &amp; Medicinal Chem.</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>02567418-12CB-462E-9092-530C6E63B359</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Chemical Biology</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>